• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

商业化可得的前列腺上皮细胞(PrEC)的分子分析与特性鉴定

Molecular analysis and characterization of PrEC, commercially available prostate epithelial cells.

作者信息

Sobel Richard E, Wang Yuzhuo, Sadar Marianne D

机构信息

Michael Smith Genome Sciences, Vancouver, British Columbia, Canada.

出版信息

In Vitro Cell Dev Biol Anim. 2006 Jan-Feb;42(1-2):33-9. doi: 10.1007/s11626-006-0009-7.

DOI:10.1007/s11626-006-0009-7
PMID:16618209
Abstract

Adenocarcinoma of the prostate comprises 95% of all prostate cancer. Commercially available primary cultures of "normal" prostate epithelial cells, PrECs, have been used as a convenient model to investigate neoplastic transformation. Here PrECs were characterized for the expression of lineage- and developmental-specific markers cytokeratin (CK) 8 and 18, p63, chromogranin A, TMEPAI, S100P, NKX 3.1, ANKH, and FN 1 as well as androgen receptor and prostate-specific antigen by Western blot and Northern blot analyses, immunohistochemistry, reverse transcriptase-polymerase chain reaction (RT-PCR), and quantitative real-time PCR. Immunohistochemical staining detected PrECs positive in varying degrees for p63, CK 8, and CK 18, with only the rare cell being positive for chromogranin A. The PrECs also tested positive for p63 protein by Western blot analysis. RT-PCR with PrEC cDNA showed products for FN 1 and S100P but not for ANKH and androgen receptor or prostate-specific antigen. This profile of markers in PrEC cells is consistent with that expected for pubertal prostate epithelial cells.

摘要

前列腺腺癌占所有前列腺癌的95%。市售的“正常”前列腺上皮细胞原代培养物(PrECs)已被用作研究肿瘤转化的便捷模型。在此,通过蛋白质免疫印迹和Northern印迹分析、免疫组织化学、逆转录聚合酶链反应(RT-PCR)和定量实时PCR,对PrECs进行了谱系和发育特异性标志物细胞角蛋白(CK)8和18、p63、嗜铬粒蛋白A、TMEPAI、S100P、NKX 3.1、ANKH和FN 1以及雄激素受体和前列腺特异性抗原表达的特征分析。免疫组织化学染色检测到PrECs对p63、CK 8和CK 18呈不同程度阳性,仅极少数细胞对嗜铬粒蛋白A呈阳性。蛋白质免疫印迹分析显示PrECs对p63蛋白也呈阳性。用PrEC cDNA进行RT-PCR显示有FN 1和S100P的产物,但没有ANKH、雄激素受体或前列腺特异性抗原的产物。PrEC细胞中的这种标志物谱与青春期前列腺上皮细胞预期的谱一致。

相似文献

1
Molecular analysis and characterization of PrEC, commercially available prostate epithelial cells.商业化可得的前列腺上皮细胞(PrEC)的分子分析与特性鉴定
In Vitro Cell Dev Biol Anim. 2006 Jan-Feb;42(1-2):33-9. doi: 10.1007/s11626-006-0009-7.
2
Intermediate basal cells of the prostate: in vitro and in vivo characterization.前列腺的中间基底细胞:体外和体内特征
Prostate. 2003 May 15;55(3):206-18. doi: 10.1002/pros.10244.
3
Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.雌激素受体(ER)-α和ER-β在正常及恶性前列腺上皮细胞中的表达:甲基化调控及其在生长调节中的作用
Cancer Res. 2000 Jun 15;60(12):3175-82.
4
Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor.正常前列腺上皮细胞和恶性前列腺上皮细胞对肝细胞生长因子/分散因子的反应不同。
Am J Pathol. 2001 Aug;159(2):579-90. doi: 10.1016/S0002-9440(10)61729-4.
5
Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer.通过基因表达序列分析对上皮细胞衰老进行特征描述:鉴定可能与前列腺癌相关的基因。
Cancer Res. 2002 Nov 1;62(21):6255-62.
6
Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells.低钙无血清限定培养基可筛选出正常前列腺上皮干细胞用于培养。
Cancer Res. 2006 Sep 1;66(17):8598-607. doi: 10.1158/0008-5472.CAN-06-1228.
7
Type 1 vasoactive intestinal peptide receptor expression in PC3/AR cells is evidence of prostate epithelial differentiation.
Prostate. 2000 Feb 1;42(2):137-44. doi: 10.1002/(sici)1097-0045(20000201)42:2<137::aid-pros8>3.0.co;2-u.
8
Expression of RFG/ELE1alpha/ARA70 in normal and malignant prostatic epithelial cell cultures and lines: regulation by methylation and sex steroids.RFG/ELE1α/ARA70在正常和恶性前列腺上皮细胞培养物及细胞系中的表达:甲基化和性类固醇的调控
Mol Carcinog. 2001 Jan;30(1):1-13. doi: 10.1002/1098-2744(200101)30:1<1::aid-mc1008>3.0.co;2-x.
9
Low p16 Expression in Early Passage Human Prostate Basal Epithelial Cells Enables Immortalization by Telomerase Expression Alone.早期传代人前列腺基底上皮细胞中低水平的p16表达仅通过端粒酶表达即可实现永生化。
Prostate. 2017 Mar;77(4):374-384. doi: 10.1002/pros.23276. Epub 2016 Nov 8.
10
A novel neoplastic primary tumor-derived human prostate epithelial cell line.一种新型的源自原发性肿瘤的人前列腺上皮细胞系。
Int J Oncol. 2003 Jun;22(6):1311-7.

引用本文的文献

1
Distinct roles for the RNA-binding protein Staufen1 in prostate cancer.Staufen1 蛋白在前列腺癌中具有不同的作用。
BMC Cancer. 2021 Feb 4;21(1):120. doi: 10.1186/s12885-021-07844-2.
2
Molecular Mechanisms and Bioavailability of Polyphenols in Prostate Cancer.多酚在前列腺癌中的分子机制与生物利用度。
Int J Mol Sci. 2019 Mar 1;20(5):1062. doi: 10.3390/ijms20051062.
3
TM4SF3 and AR: A Nuclear Complex that Stabilizes Both Proteins.跨膜4超家族成员3(TM4SF3)与雄激素受体(AR):一种使两种蛋白质均得以稳定的核复合物

本文引用的文献

1
Primary cell cultures as models of prostate cancer development.原代细胞培养作为前列腺癌发展的模型
Endocr Relat Cancer. 2005 Mar;12(1):19-47. doi: 10.1677/erc.1.00795.
2
Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.通过小干扰RNA(siRNA)沉默polo样激酶(Plk)1可诱导人前列腺癌细胞凋亡并损害有丝分裂机制:对前列腺癌治疗的启示。
FASEB J. 2005 Apr;19(6):611-3. doi: 10.1096/fj.04-2910fje. Epub 2005 Jan 20.
3
Cell lines used in prostate cancer research: a compendium of old and new lines--part 2.
Mol Endocrinol. 2016 Jan;30(1):13-25. doi: 10.1210/me.2015-1075. Epub 2015 Dec 9.
4
β4 Integrin signaling induces expansion of prostate tumor progenitors.β4 整合素信号诱导前列腺肿瘤祖细胞扩增。
J Clin Invest. 2013 Feb;123(2):682-99. doi: 10.1172/JCI60720. Epub 2013 Jan 25.
5
Repression of androgen receptor transcription through the E2F1/DNMT1 axis.通过 E2F1/DNMT1 轴抑制雄激素受体转录。
PLoS One. 2011;6(9):e25187. doi: 10.1371/journal.pone.0025187. Epub 2011 Sep 26.
6
Thioredoxin 1 as a subcellular biomarker of redox imbalance in human prostate cancer progression.硫氧还蛋白 1 作为人类前列腺癌进展中氧化还原失衡的亚细胞生物标志物。
Free Radic Biol Med. 2010 Dec 15;49(12):2078-87. doi: 10.1016/j.freeradbiomed.2010.10.691. Epub 2010 Oct 16.
7
The current state of preclinical prostate cancer animal models.临床前前列腺癌动物模型的现状。
Prostate. 2008 May 1;68(6):629-39. doi: 10.1002/pros.20726.
前列腺癌研究中使用的细胞系:新旧细胞系汇编——第2部分
J Urol. 2005 Feb;173(2):360-72. doi: 10.1097/01.ju.0000149989.01263.dc.
4
Cell lines used in prostate cancer research: a compendium of old and new lines--part 1.前列腺癌研究中使用的细胞系:新旧细胞系汇编——第1部分
J Urol. 2005 Feb;173(2):342-59. doi: 10.1097/01.ju.0000141580.30910.57.
5
Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer.白细胞介素-6是S100P的强效诱导剂,S100P在雄激素难治性和转移性前列腺癌中上调。
Int J Biochem Cell Biol. 2005 Feb;37(2):442-50. doi: 10.1016/j.biocel.2004.07.011.
6
NKX3.1 expression is lost in testicular germ cell tumors.NKX3.1表达在睾丸生殖细胞肿瘤中缺失。
Am J Pathol. 2003 Dec;163(6):2149-54. doi: 10.1016/S0002-9440(10)63571-7.
7
An antibody against DR4 (TRAIL-R1) in combination with doxorubicin selectively kills malignant but not normal prostate cells.一种抗DR4(TRAIL-R1)抗体与阿霉素联合使用可选择性地杀死恶性前列腺细胞,而不损伤正常前列腺细胞。
Cancer Biol Ther. 2003 May-Jun;2(3):283-90. doi: 10.4161/cbt.2.3.398.
8
Intermediate basal cells of the prostate: in vitro and in vivo characterization.前列腺的中间基底细胞:体外和体内特征
Prostate. 2003 May 15;55(3):206-18. doi: 10.1002/pros.10244.
9
Transcriptional programs activated by exposure of human prostate cancer cells to androgen.人前列腺癌细胞暴露于雄激素后激活的转录程序。
Genome Biol. 2002 Jun 14;3(7):RESEARCH0032. doi: 10.1186/gb-2002-3-7-research0032.
10
Processing of gene expression data generated by quantitative real-time RT-PCR.定量实时逆转录聚合酶链反应生成的基因表达数据的处理
Biotechniques. 2002 Jun;32(6):1372-4, 1376, 1378-9.